Answers are grounded in this paper and cite their sources.
We report how the reaction mechanism and site-selectivity of 2-halopyridine oxidative addition to L2Pd(0) are both controlled by frontier molecular orbital symmetry. Comparing oxidative addition rates for pairs of 2-chloro-3-EDG-pyridines / 2-chloro-5-EDG-pyridines (EDG = electron-donating group: NH2, OMe and F) to Pd(PCy3)2 reveals the 3-EDG isomers undergo oxidative addition ~100 times faster than their 5-EDG counterparts (∆ΔG‡OA = 10.4-11.6 kJ mol-1). Experimental and computational mechanistic studies reveal that the LUMO symmetries of the substrates control the oxidative addition mechanism. For the 3-EDG derivatives, high LUMO orbital coefficients at the reactive C2 position, and antibonding LUMO symmetry through the C2=N bond of the pyridine lead to a nucleophilic displacement oxida-tive addition mechanism. Conversely, the LUMO of the 5-EDG derivatives has a node through the C5–C2 plane, lead-ing to minimal orbital contribution at the reactive carbon. The higher energy LUMO+1 has substantial density at C2, but minimal orbital density at the nitrogen. This leads to 5-EDG substrates undergoing a 3-centered insertion oxida-tive addition mechanism. These orbital symmetry effects also control site-selectivity for multihalogenated pyridines, which we investigate for both electron-donating and electron-withdrawing substituents. Incorporating simple fron-tier orbital based molecular descriptors to a quantitative multivariate linear model for oxidative addition leads to im-proved prediction accuracy for both relative rates and site-selectivity of substituted 2-halopyridine oxidative addition to L2Pd(0).
No takes yet. Share an insight, caveat, or question.
Lu et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: